Nav: Home

Is increased BMI associated with reduced risk of premenopausal breast cancer?

June 21, 2018

BottomLine: Higher body mass index (BMI), especially in early adulthood, may be associated with reduced risk for premenopausal breast cancer.

Why The Research Is Interesting: Breast cancer is the most commonly diagnosed cancer among women. Breast cancer's origin is complex and it includes a wide range of factors, among them how much body fat a woman has, a measure often assessed by BMI (a calculation of weight in kilograms divided by height in meters squared). Previous research suggests increasing BMI may be associated with reduced risk for premenopausal breast cancer but increased risk after menopause. This study sought to undertake a more rigorous and systematic analysis of the association between BMI and risk of premenopausal breast cancer using pooled data from 19 studies.

Who and When: 758,592 premenopausal women from 19 studies (recruited from 1963 to 2013); there were 13,082 new cases of breast cancer over roughly nine years of follow-up per participant

What (Study Measures and Outcomes): BMI at ages 18 to 24, 25 to 34, 35 to 44 and 45 to 54 (exposures); invasive or noninvasive (in situ) premenopausal breast cancer

Study Design: This was an observational study. Researchers were not intervening for purposes of the study and cannot totally control for all the natural differences that could explain the study results.

Authors: Premenopausal Breast Cancer Collaborative Group (Minouk J. Schoemaker, Ph.D., of the Institute of Cancer Research, London, United Kingdom, is the corresponding author)

Results: The analysis suggests an "inverse association" of breast cancer risk with BMI for women between the ages of 18 and 54, which means breast cancer risk decreased as BMI increased. The association was strongest for BMI in early adulthood between the ages of 18 and 24.

Limitations: The study used BMI as its measure but women with the same BMI can have different body fat distributions and overall levels of body fat; weight was often self-reported and some women over report or under report their weight

Study Conclusions: Study authors are not advocating weight gain as a way to reduce premenopausal breast cancer risk. Understanding the reasons for the association seen between BMI and premenopausal breast cancer risk could potentially help to identify risk factors that might be modified.

To Learn More: The full study is available on the For The Media website.

(doi:10.1001/jamaoncol.2018.1771)

Editor's Note: The article contains funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
-end-
Want to embed a link to this study in your story?: Links will be live at the embargo time http://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2018.1771

JAMA Oncology

Related Breast Cancer Articles:

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.
Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.
More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.
Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.
Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.
Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.
Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.
Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.
Does MRI plus mammography improve detection of new breast cancer after breast conservation therapy?
A new article published by JAMA Oncology compares outcomes for combined mammography and MRI or ultrasonography screenings for new breast cancers in women who have previously undergone breast conservation surgery and radiotherapy for breast cancer initially diagnosed at 50 or younger.
Blood test offers improved breast cancer detection tool to reduce use of breast biopsy
A Clinical Breast Cancer study demonstrates Videssa Breast can inform better next steps after abnormal mammogram results and potentially reduce biopsies up to 67 percent.
More Breast Cancer News and Breast Cancer Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.